Analysis Attacks Stem–Cell Data in CHD, Another Gives Tepid SupportMedscapeLONDON, UK — The promise of autologous stem–cell therapy for ischemic heart disease has either taken an existential hit, if one agrees with an analysis in this week’s literature, or deserves subdued, provisional approval if one favors another. The … …read more &nbs… Continue reading
Guardian Liberty VoiceThe stem cell powder and sheets will soon be undergoing several types of clinical trials. In the first trial, a woman suffering from esophageal cancer will have the stem cells placed in her esophagus after surgery to see if the tissues there will … …read more &nbs… Continue reading
Stem Cell Cloning May be Aid Treatment for DiabetesThe Charlottesville NewsplexThe new work is a step toward providing genetically matched replacement cells for transplant, said Dieter Egli of the New York Stem Cell Foundation Research Institute in New York. He led the research, which was reported online Monday in the journal … …read more &nbs… Continue reading
Stem cell breakthrough: patient-specific therapies for type 1 diabetesMedical News TodayA team of scientists from the New York Stem Cell Foundation Research Institute and Columbia University Medical Center, also in New York, claim to have created the first disease-specific embryonic stem cell line with two sets of chromosomes. The … …read more &nbs… Continue reading
Doubts over heart stem–cell therapyNature.comEarly-phase clinical trials have reported that adult stem cells are effective in treating heart attack and heart failure, and many companies are moving quickly to tap into this potentially lucrative market. But a comprehensive study that looked at … …read more &nbs… Continue reading
Genetic Engineering NewsFour studies published in recent weeks are giving researchers new hope that key hurdles hobbling stem cell research can finally be overcome—while renewing fears that the reported advances will lead to reproductive cloning. Researchers on Monday … …read more &nbs… Continue reading
RedOrbitResearchers reported on Monday the creation of the first disease-specific line of embryonic stem cells made with a patient’s own DNA, a major breakthrough in field of regenerative medicine. The achievement marks the first time cloning technologies have … …read more &nbs… Continue reading
GizmagDr. Rocky Tuan, director of the Center for Cellular and Molecular Engineering at the University of Pittsburgh School of Medicine, is working on techniques that give a patient’s stem cells the perfect conditions to grow into healthy cartilage …Cartilage-on-a-Chip Success Stirs Hopes for Joint RepairGenetic Engineering News all 10 news articles …read more &nbs… Continue reading